A Parallel, Double-blind, Placebo Controlled, Randomized Comparison of an Anti-Digoxin Antibody (Digibind) Versus Placebo for the Treatment of Antepartum Patients With Severe Preeclampsia.

Trial Profile

A Parallel, Double-blind, Placebo Controlled, Randomized Comparison of an Anti-Digoxin Antibody (Digibind) Versus Placebo for the Treatment of Antepartum Patients With Severe Preeclampsia.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Dec 2016

At a glance

  • Drugs Anti-digoxin polyclonal antibody (Primary)
  • Indications Preeclampsia
  • Focus Proof of concept; Therapeutic Use
  • Acronyms DEEP
  • Most Recent Events

    • 06 Jan 2011 Results have been published (American Journal of Perinatology; 27(8): 655-662).
    • 25 Sep 2008 Additional analysis presented at the 16th World Congress of the International Society for the Study of Hypertension in Pregnancy in Sep 2008.
    • 22 Jul 2008 Data are under review by a potential licensing partner; In addition, data from the study will be presented in international conferences later this year, reported by Protherics in a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top